Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Summary

The purpose of this study is to confirm the efficacy and safety of 800 mg Chondroitin 4\&6 sulfate (Condrosulf) vs placebo once a day for 6 months in the symptomatic treatment of knee osteoarthritis. A third group, Celecoxib 200 mg (Celebrex) once a day, will be used as active comparator.

Timeline

Start

2014-06-12

Primary completion

2015-10-19

Completion

2016-06-16

Drugs

Indications